Preclinical evaluation of LCK as a novel therapeutic target in YAP-activated and FGFR2-altered cholangiocarcinomaCaitlin Conboy,Jennifer Yonkus, Eee L. N. Buckarma,Dong-Gi Mun,Nathan Werneburg,Ryan Watkins,Yi Guo,Juan Wang,Daniel O'Brien, Rogier Buijsman,Diep Vu,Jos De Man,Sumera Ilyas,Mark J. Truty,Mitesh J. Borad,Akhilesh Pandey,Gregory J. Gores,Rory L. SmootJOURNAL OF CLINICAL ONCOLOGY(2022)引用 1|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要